News & Press.
Learn the Latest Aziyo Updates
Aziyo Biologics Announces Pricing of Initial Public Offering
SILVER SPRING, Md., Oct. 07, 2020 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) today announced the pricing of its initial public offering of 2,941,176 shares of common stock, consisting of 2,205,882 shares of Class A common stock and...
Aziyo Biologics Announces Appointment of Chief Financial Officer
SILVER SPRING, Md. – September 28, 2020 – Aziyo Biologics, Inc. (“Aziyo”), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery,...
Aziyo Biologics Announces New Appointments to Board of Directors
SILVER SPRING, Md., Sept. 21, 2020 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (“Aziyo”), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients...
Aziyo Biologics Announces Launch of OsteGro® V
Expands Regenerative Medicine Product Portfolio and Leverages Proprietary Processing Platform to Protect and Preserve Native Bone Cells Silver Spring, Md. – June 29, 2020 – Aziyo Biologics, Inc. (“Aziyo”), a commercial-stage, regenerative medicine...
Aziyo Biologics® Announces Exclusive Agreement with Medtronic® to Distribute FiberCel®
Silver Spring, Md. – June 20, 2019 – Aziyo Biologics, Inc., a fully integrated regenerative medicine company, announced today it has signed an exclusive, multi-year distribution agreement with Medtronic for the U.S. orthopedic market. Per the...